Rheumatology >
General Rheumatology
News, opinions and meeting coverage in rheumatology.
Rituxan Offers Little Help for Sjogren's
Treatment for primary Sjogren's syndrome with the B-cell depleting antibody rituximab (Rituxan) failed to provide statistically significant improvements, despite the increasing evidence for B cells in the pathogenesis of this disorder, French researchers reported.
Feb 18, 2014